Skip to main content

Advertisement

SpringerLink
Log in

Isolation and Antifungal Susceptibility of Exophiala dermatitidis Isolates from Human Stool Samples in Nigeria

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

We screened a total of 460 stool samples from humans with and without underlying disease for the black yeast and neurotrope, Exophiala dermatitidis using conventional and molecular identification procedures. Sixteen (3.5%) samples were positive. Twelve out of the sixteen positive samples where the fungus was recovered were from individuals who had diarrhoea at the moment of isolation. Two asymptomatic positive cases were within the age bracket of 21–30. Susceptibility testing of the strains using the CLSI M38 protocol suggests that almost all the strains were susceptible to amphotericin B, 5 fluorocytosine, itraconazole, fluconazole and voriconazole. Considering the health risk currently posed by this organism in Asia, especially among healthy younger subjects of the population and the scarcity of data on this fungus in Africa in general and Nigeria in particular, some recommendations were suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. De Hoog GS, Matos T, Sudhadham M, Luijsterburg KF, Haase G. Intestinal prevalence of the neutropic black yeast Exophiala (Wangiella) dermatitidis in healthy and impaired individuals. Mycoses. 2005;48:142–5.

    Article  PubMed  Google Scholar 

  2. De Hoog GS, Zeng JS, Harrak MJ, Sutton DA. Exophiala xenobiotica sp. nov., an opportunistic black yeast inhabiting environments rich in hydrocarbons. Antonie Leeuwenhoek. 2006;90:257–68.

    Article  PubMed  CAS  Google Scholar 

  3. Matos T, Haase G, Gerrits van den Ende AHG, De Hoog GS. Molecular diversity of oligotrophic and neurotropic members of the black yeast genus Exophiala, with accent on E. dermatitidis. Antonie Van Leeuwenhoek. 2003;83:293–303.

    Article  CAS  PubMed  Google Scholar 

  4. Hiruma M, Kawada A, Ohata H, et al. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses. 1993;36:1–7.

    CAS  PubMed  Google Scholar 

  5. Matsumoto T, Matsuda T, McGinnis MR, Aiello L. Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses. 1993;36:145–55.

    CAS  PubMed  Google Scholar 

  6. Chang HL, Kim DS, Park DJ, Kim HJ, Lee CH, Shin HJ. Acute cerebral phaeohyphomycosis due to Wangiella dermatitidis accompanied by cerebrospinal eosinophilia. J Clin Microbiol. 2000;38:1965–6.

    CAS  PubMed  Google Scholar 

  7. Haase G, Skopnik H, Groten T, Kusenbach G, Posselt H-G. Long-term fungal cultures from patients with cystic fibrosis. Mycoses. 1991;34:373–6.

    Article  CAS  PubMed  Google Scholar 

  8. Ajanee N, Alam M, Holmberg K, Khan J. Brain abscess caused by Wangiella dermatitidis: case report. Clin infect Dis. 1996;23:197–8.

    CAS  PubMed  Google Scholar 

  9. Nweze EI, Curs-breuker I, Janssen B, de Hoog GS, Meis JF. In vitro activity of posaconazole compared with other antifungal agents against 95 strains of Exophiala dermatitidis against seven antifungal agents. Proceedings of the 46th interscience conference on antimicrobial agents and chemotherapy, San Fransisco. September 27–30, 2006. pp 420

  10. Fothergill AW, Rinaldi MG, Sutton DA. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole. Med Mycol. 2009;47(1):41–3.

    Article  CAS  PubMed  Google Scholar 

  11. de Hoog GS, Haase G. Nutritional physiology and selective isolation of Exophiala dermatitidis. Antonie Van Leeuwenhoek. 1993;64:17–26.

    Article  PubMed  Google Scholar 

  12. National Committee for Clinical Laboratory Standards. Reference method for broth dilution susceptibility testing of filamentous fungi: approved standard. NCCLS document M38-A. Wayne, PA: National Committee for Laboratory Clinical Standards; 2002.

    Google Scholar 

  13. Sudhadham M, Prakitsin S, Sivichai S, Chaiyarat R, Dorrestein GM, Menken SB, et al. The neurotropic black yeast Exophiala dermatitidis has a possible origin in the tropical rain forest. Stud Mycol. 2008;61:145–55.

    Article  CAS  PubMed  Google Scholar 

  14. Zeng JS, Sutton DA, Fothergill AW, Rinaldi MG, Harrak MJ, de Hoog GS. Spectrum of clinically relevant Exophiala species in the United States. J Clin Microbiol. 2007;45(11):3713–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. E. I. Nweze

    Present address: Center for Medical Mycology, Department of Dermatology, Case Western Reserve University, Cleveland, USA

Authors and Affiliations

  1. Department of Microbiology, University of Nigeria, Nsukka, Enugu State, Nigeria

    E. I. Nweze

  2. Department of Applied Microbiology, Ebonyi State University, Abakiliki, Ebonyi State, Nigeria

    E. I. Nweze & S. Ezute

Authors
  1. E. I. Nweze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Ezute
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. I. Nweze.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nweze, E.I., Ezute, S. Isolation and Antifungal Susceptibility of Exophiala dermatitidis Isolates from Human Stool Samples in Nigeria. Mycopathologia 169, 201–206 (2010). https://doi.org/10.1007/s11046-009-9244-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-009-9244-2

Keywords

Search

Navigation